Literature DB >> 18753353

Femoral prosthesis infection by Rhodotorula mucilaginosa.

Vincenzo Savini1, Federica Sozio, Chiara Catavitello, Marzia Talia, Assunta Manna, Fabio Febbo, Andrea Balbinot, Giovanni Di Bonaventura, Raffaele Piccolomini, Giustino Parruti, Domenico D'Antonio.   

Abstract

This case report is a case history of a femoral prosthesis infection caused by Rhodotorula mucilaginosa in a human immunodeficiency virus patient. Though the pathogenicity of this organism for bone tissue has been previously reported, this is the first reported case of an orthopedic prosthesis infection by this species of the genus Rhodotorula.

Entities:  

Mesh:

Year:  2008        PMID: 18753353      PMCID: PMC2566075          DOI: 10.1128/JCM.00873-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples.

Authors:  F Galán-Sánchez; P García-Martos; C Rodríguez-Ramos; P Marín-Casanova; J Mira-Gutiérrez
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Rhodotorula minuta: an unusual fungal infection in hip-joint prosthesis.

Authors:  Anthony F Cutrona; Munir Shah; Melissa S Himes; Michael A Miladore
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2002-03

Review 3.  Rhodotorula species fungemia: a threat to the immunocompromised host.

Authors:  Maria Anatoliotaki; Elpis Mantadakis; Emmanuel Galanakis; George Samonis
Journal:  Clin Lab       Date:  2003       Impact factor: 1.138

4.  Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.

Authors:  Alicia Gomez-Lopez; Emilia Mellado; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  J Antimicrob Chemother       Date:  2005-02-04       Impact factor: 5.790

5.  Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.

Authors:  A Espinel-Ingroff; M Pfaller; S A Messer; C C Knapp; S Killian; H A Norris; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 6.  Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature.

Authors:  G Samonis; M Anatoliotaki; H Apostolakou; S Maraki; D Mavroudis; V Georgoulias
Journal:  Infection       Date:  2001 May-Jun       Impact factor: 3.553

7.  Rhodotorula mucilaginosa as a cause of persistent femoral nonunion.

Authors:  R Goyal; S Das; A Arora; A Aggarwal
Journal:  J Postgrad Med       Date:  2008 Jan-Mar       Impact factor: 1.476

8.  Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters.

Authors:  D K Braun; C A Kauffman
Journal:  Mycoses       Date:  1992 Nov-Dec       Impact factor: 4.377

9.  Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.

Authors:  Aimee K Zaas; Molly Boyce; Wiley Schell; Barbara Alexander Lodge; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; J F Meis; I M Gould; W Fu; A L Colombo; E Rodriguez-Noriega
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

View more
  5 in total

1.  Marchiafava-Bignami disease: a rare entity with a poor outcome.

Authors:  Paulo Eduardo Mestrinelli Carrilho; Marcius Benigno Marques Dos Santos; Larisa Piasecki; Amaury Cezar Jorge
Journal:  Rev Bras Ter Intensiva       Date:  2013-03

2.  Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.

Authors:  Maral Gharaghani; Simin Taghipour; Ali Zarei Mahmoudabadi
Journal:  Mol Biol Rep       Date:  2020-11-01       Impact factor: 2.316

3.  Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.

Authors:  Jorge Meneses Nunes; Fernando César Bizerra; Renata Carmona E Ferreira; Arnaldo Lopes Colombo
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

4.  Epidemiology of Rhodotorula: an emerging pathogen.

Authors:  Fernanda Wirth; Luciano Z Goldani
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-02

5.  Reversible naftifine-induced carotenoid depigmentation in Rhodotorula mucilaginosa (A. Jörg.) F.C. Harrison causing onychomycosis.

Authors:  Augustin C Moț; Marcel Pârvu; Alina E Pârvu; Oana Roşca-Casian; Nicoleta E Dina; Nicolae Leopold; Radu Silaghi-Dumitrescu; Cristina Mircea
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.